<p>The results presented represent geometric means (SD), adjusted for age, race and gender.</p><p><sup>a</sup>vs control group</p><p><sup>b</sup>vs non-diabetic metabolic syndrome group</p><p><sup>c</sup>vs type 2 diabetes mellitus without metabolic syndrome which evaluated using univariate (General Linear Model).</p><p>Bold values are significant. MetS: metabolic syndrome.</p><p>Comparison of fasting serum levels of sCD26/DPP-IV and active GLP-1 between normal, non-diabetic metabolic syndrome, type 2 diabetes mellitus subjects with and without metabolic syndrome and total type 2 diabetes mellitus.</p
The first row shows prevalence of MS based on JIS-HbA1c ≥5.75% (≥39.3 mmol/mol) and JIS criteria, ov...
Aims: To determine whether fasting plasma Dipeptidyl Peptidase 4 (DPP4) activity and active Glucagon...
<p>Data are expressed as mean+SEM. Sample size is indicated inside the column and the number of men ...
<p>The results are presented as r<sub>s</sub> and (P-value) assessed by Spearman partial correlation...
<p>The results presented represent geometric means (SD), adjusted for age, gender, and race</p><p><s...
<p>The results are presented as unstandardized coefficients; B, r<sup>2</sup> and (P-value) assessed...
<p>The results are presented as unstandardized coefficients; B and (P-value) assessed using multiple...
<p>The results presented represent geometric means (SD)</p><p><sup>a</sup><i>vs</i> normal control g...
<p>Comparison of circulating levels of FGF19 and FGF21 between diabetic (T2D) and non-diabetic (No-T...
<p>Diagnostic criteria for diabetes using FPG ≥7.0 mmol/l and/or HbA1c ≥48 mmol/mol (6.5%). Data are...
A soluble form of CD26/dipeptidyl peptidase-IV (sCD26/DPP-IV) induces DPP-IV enzymatic activity that...
Background: Glucagon-Like Peptide-1 (GLP-1) is hydrolyzed by Dipeptidyl-Peptidase 4 (DPP4), and seve...
Glucagon-Like Peptide-1 (GLP-1) is hydrolyzed by Dipeptidyl-Peptidase 4 (DPP4), and several studies ...
A soluble form of CD26/dipeptidyl peptidase-IV (sCD26/DPP-IV) induces DPP-IV enzymatic activity that...
<p>(A): presence or absence of HTGW in the whole population; (B): presence or absence of MetS in the...
The first row shows prevalence of MS based on JIS-HbA1c ≥5.75% (≥39.3 mmol/mol) and JIS criteria, ov...
Aims: To determine whether fasting plasma Dipeptidyl Peptidase 4 (DPP4) activity and active Glucagon...
<p>Data are expressed as mean+SEM. Sample size is indicated inside the column and the number of men ...
<p>The results are presented as r<sub>s</sub> and (P-value) assessed by Spearman partial correlation...
<p>The results presented represent geometric means (SD), adjusted for age, gender, and race</p><p><s...
<p>The results are presented as unstandardized coefficients; B, r<sup>2</sup> and (P-value) assessed...
<p>The results are presented as unstandardized coefficients; B and (P-value) assessed using multiple...
<p>The results presented represent geometric means (SD)</p><p><sup>a</sup><i>vs</i> normal control g...
<p>Comparison of circulating levels of FGF19 and FGF21 between diabetic (T2D) and non-diabetic (No-T...
<p>Diagnostic criteria for diabetes using FPG ≥7.0 mmol/l and/or HbA1c ≥48 mmol/mol (6.5%). Data are...
A soluble form of CD26/dipeptidyl peptidase-IV (sCD26/DPP-IV) induces DPP-IV enzymatic activity that...
Background: Glucagon-Like Peptide-1 (GLP-1) is hydrolyzed by Dipeptidyl-Peptidase 4 (DPP4), and seve...
Glucagon-Like Peptide-1 (GLP-1) is hydrolyzed by Dipeptidyl-Peptidase 4 (DPP4), and several studies ...
A soluble form of CD26/dipeptidyl peptidase-IV (sCD26/DPP-IV) induces DPP-IV enzymatic activity that...
<p>(A): presence or absence of HTGW in the whole population; (B): presence or absence of MetS in the...
The first row shows prevalence of MS based on JIS-HbA1c ≥5.75% (≥39.3 mmol/mol) and JIS criteria, ov...
Aims: To determine whether fasting plasma Dipeptidyl Peptidase 4 (DPP4) activity and active Glucagon...
<p>Data are expressed as mean+SEM. Sample size is indicated inside the column and the number of men ...